Industry / Canada
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Apotex Expands In Europe
November 2007 | FDI AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Leading Canadian generics firm Apotex has acquired Belgian drugmaker Topgen for an undisclosed fee. In doing so, the North American company will increase its footprint in Europe, whilst gaining a launching pad in the EU for many of its products currently in development.